Drug-eluting balloons for the treatment of the superficial femoral artery in-stent restenosis: 2-year follow-up

JACC: Cardiovascular Interventions

Volumn 7, Issue 4, 2014, Pages 411-415

  Virga, Vittorio ^a   Stabile, Eugenio ^b   Biamino, Giancarlo ^c   Salemme, Luigi ^c   Cioppa, Angelo ^c   Giugliano, Giuseppe ^b   Tesorio, Tullio ^c   Cota, Linda ^c   Popusoi, Grigore ^c   Pucciarelli, Armando ^c   Esposito, Giovanni ^c   Trimarco, Bruno ^b   Rubino, Paolo ^c  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Clinica Montevergine   (Italy)

Author keywords

drug eluting balloon; in stent restenosis; superficial femoral artery

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; PACLITAXEL; TICLOPIDINE; BIOMATERIAL; CARDIOVASCULAR AGENT;

ADULT; ANKLE BRACHIAL INDEX; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVASCULAR MORTALITY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEVICE SAFETY; DRUG ELUTING BALLOON; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; IN-STENT RESTENOSIS; MALE; NITINOL STENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY BALLOON; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; SUDDEN DEATH; SUPERFICIAL FEMORAL ARTERY; SUSTAINED RELEASE PREPARATION; CENTRAL VENOUS CATHETER; EQUIPMENT DESIGN; FEMORAL ARTERY; ITALY; PERIPHERAL ARTERIAL DISEASE; REGISTER; RETREATMENT; STENOSIS, OCCLUSION AND OBSTRUCTION; STENT; TIME; TREATMENT OUTCOME; CLINICAL EVALUATION; DRUG ELUTING STENT; ECHOGRAPHY; GRAFT PATENCY; SELF EXPANDING NITINOL STENT;

ANGIOPLASTY, BALLOON; CARDIOVASCULAR AGENTS; COATED MATERIALS, BIOCOMPATIBLE; CONSTRICTION, PATHOLOGIC; EQUIPMENT DESIGN; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; ITALY; PACLITAXEL; PERIPHERAL ARTERIAL DISEASE; PROSPECTIVE STUDIES; RECURRENCE; REGISTRIES; RETREATMENT; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR ACCESS DEVICES;

EID: 84898784466     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2013.11.020     Document Type: Article

References (13)

1. J.R. Laird, and K.K. Yeo The treatment of femoropopliteal in-stent restenosis: back to the future J Am Coll Cardiol 59 2012 24 25
2. E. Stabile, V. Virga, and L. Salemme et al. Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis J Am Coll Cardiol 60 2012 1739 1742
3. A. Micari, A. Cioppa, and G. Vadalà et al. 2-year results of paclitaxel-eluting balloons for femoropopliteal artery disease: evidence from a multicenter registry J Am Coll Cardiol Intv 6 2013 282 289
4. A. Micari, A. Cioppa, and G. Vadalà et al. A new paclitaxel-eluting balloon for angioplasty of femoropopliteal obstructions: acute and midterm results EuroIntervention 7 Suppl K 2011 K77 K82
5. A. Tosaka, Y. Soga, O. Iida, and Ishihara et al. Classification and clinical impact of restenosis after femoropopliteal stenting J Am Coll Cardiol 59 2012 16 23
6. D. Scheinert, S. Scheinert, and J. Sax et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting J Am Coll Cardiol 45 2005 312 315
7. P. Dick, S. Sabeti, and W. Mlekusch et al. Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: initial experience Radiology 248 2008 297 302
8. C. Indolfi, E. Stabile, C. Perrino, and M. Chiariello Mechanisms of restenosis after angioplasty and approach to therapy Int J Mol Med 2 1998 143 148
9. D.I. Axel, W. Kunert, and C. Göggelmann et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery Circulation 96 1997 636 645
10. F. Liistro, P. Angioli, and I. Porto et al. Paclitaxel-eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE-ISR study J Endovasc Ther 21 2014 1 8
11. T. Zeller, M.D. Dake, and G. Tepe et al. Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents J Am Coll Cardiol Intv 6 2013 274 281
12. S. Duda, B. Pusich, and G. Richter et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results Circulation 106 2002 1505 1509
13. S.H. Duda, M. Bosiers, and J. Lammer et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial J Vasc Interv Radiol 16 2005 331 338